Mecanismo de acción de moléculas con actividad biológica ; Mechanisms of action of biolocally active compounds
Moabac
Karolinska Institute
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska Institute (5)
2012
-
Introduction of a fluorine atom at C3 of 3-deazauridine shifts its antimetabolic activity from inhibition of CTP synthetase to inhibition of orotidylate decarboxylase, an early event in the de novo pyrimidine nucleotide biosynthesis pathway
Journal of Biological Chemistry, Vol. 287, Núm. 36, pp. 30444-30454
2011
-
Synthesis, modeling and evaluation of 3′-(1-aryl-1H-tetrazol-5- ylamino)-substituted 3′-deoxythymidine derivatives as potent and selective human mitochondrial thymidine kinase inhibitors
Organic and Biomolecular Chemistry, Vol. 9, Núm. 3, pp. 892-901
2010
-
3′-[4-Aryl-(1,2,3-triazol-1-yl)]-3′-deoxythymidine analogues as potent and selective inhibitors of human mitochondrial thymidine kinase
Journal of Medicinal Chemistry, Vol. 53, Núm. 7, pp. 2902-2912
2006
-
N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors
Journal of Medicinal Chemistry, Vol. 49, Núm. 26, pp. 7766-7773
2003
-
Improving the selectivity of acyclic nucleoside analogues as inhibitors of human mitochondrial thymidine kinase: Replacement of a triphenylmethoxy moiety with substituted amines and carboxamides
Bioorganic and Medicinal Chemistry Letters, Vol. 13, Núm. 18, pp. 3027-3030